Six novel minimally invasive therapies for benign prostatic hyperplasia
Benign prostatic hyperplasia (BPH) is the most common cause of lower urinary tract symptoms in men. When drug treatment is ineffective or conventional surgery is not suitable, novel minimally invasive therapies can be considered. These include prostatic urethral lift, prostatic artery embolisation,...
Gespeichert in:
| Veröffentlicht in: | Zhejiang da xue xue bao. Journal of Zhejiang University. Medical sciences. Yi xue ban 2023-04, Vol.52 (2), p.162-168 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 168 |
|---|---|
| container_issue | 2 |
| container_start_page | 162 |
| container_title | Zhejiang da xue xue bao. Journal of Zhejiang University. Medical sciences. Yi xue ban |
| container_volume | 52 |
| creator | Niu, Xinyang Liu, Ben |
| description | Benign prostatic hyperplasia (BPH) is the most common cause of lower urinary tract symptoms in men. When drug treatment is ineffective or conventional surgery is not suitable, novel minimally invasive therapies can be considered. These include prostatic urethral lift, prostatic artery embolisation, water vapor thermal therapy, Aquablation-image guided robotic waterjet ablation, temporary implantable nitinol device and prostatic stents. These novel therapies can be performed in outpatient setting under local anesthesia, with shorter operative and recovery times, and better protection of ejaculatory function and erectile function. General conditions of the patient and advantages and disadvantages of the each of these therapies should be fully considered to make individualized plans. |
| doi_str_mv | 10.3724/zdxbyxb-2022-0593 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2823495236</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2823495236</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1413-f6f84b4f4fb3aa703965eaf90be7cc25e8685f7eb37127e319fe47ebe477085e3</originalsourceid><addsrcrecordid>eNo9kDtPAzEQhF2ASBTyA2iQS5oDP8--EkWQIEWiAGrLvqyJ0b04X6Icvx5HCTS7WmlmNPshdEPJPVdMPPxsDm48uIwRxjIiC36BppQQnRWsYBM0j_GLEMIkUZrRKzRJJs2TYIqWb-GAm3YPFa5DE2pbVSMOzd7GsAc8bKG3XYCIfdtjB034bHDXt3GwQyjxduyg76qktdfo0tsqwvy8Z-jj-el9scrWr8uXxeM6K6mgPPO518IJL7zj1irCi1yC9QVxoMqSSdC5ll6B44oyBZwWHkQ601BES-AzdHfKTS2-dxAHU4dYQlXZBtpdNEwzLgrJeJ6k9CQtU-HYgzddnx7sR0OJOWIzZ2zmiM0csSXP7Tl-52rY_Dv-gPFfAFxtSA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2823495236</pqid></control><display><type>article</type><title>Six novel minimally invasive therapies for benign prostatic hyperplasia</title><source>PubMed (Medline)</source><source>MEDLINE</source><creator>Niu, Xinyang ; Liu, Ben</creator><creatorcontrib>Niu, Xinyang ; Liu, Ben</creatorcontrib><description>Benign prostatic hyperplasia (BPH) is the most common cause of lower urinary tract symptoms in men. When drug treatment is ineffective or conventional surgery is not suitable, novel minimally invasive therapies can be considered. These include prostatic urethral lift, prostatic artery embolisation, water vapor thermal therapy, Aquablation-image guided robotic waterjet ablation, temporary implantable nitinol device and prostatic stents. These novel therapies can be performed in outpatient setting under local anesthesia, with shorter operative and recovery times, and better protection of ejaculatory function and erectile function. General conditions of the patient and advantages and disadvantages of the each of these therapies should be fully considered to make individualized plans.</description><identifier>ISSN: 1008-9292</identifier><identifier>DOI: 10.3724/zdxbyxb-2022-0593</identifier><identifier>PMID: 37283100</identifier><language>eng</language><publisher>China</publisher><subject>Embolization, Therapeutic - adverse effects ; Humans ; Lower Urinary Tract Symptoms - etiology ; Lower Urinary Tract Symptoms - surgery ; Male ; Minimally Invasive Surgical Procedures ; Prostatic Hyperplasia - complications ; Prostatic Hyperplasia - surgery ; Stents - adverse effects ; Treatment Outcome</subject><ispartof>Zhejiang da xue xue bao. Journal of Zhejiang University. Medical sciences. Yi xue ban, 2023-04, Vol.52 (2), p.162-168</ispartof><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c1413-f6f84b4f4fb3aa703965eaf90be7cc25e8685f7eb37127e319fe47ebe477085e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37283100$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Niu, Xinyang</creatorcontrib><creatorcontrib>Liu, Ben</creatorcontrib><title>Six novel minimally invasive therapies for benign prostatic hyperplasia</title><title>Zhejiang da xue xue bao. Journal of Zhejiang University. Medical sciences. Yi xue ban</title><addtitle>Zhejiang Da Xue Xue Bao Yi Xue Ban</addtitle><description>Benign prostatic hyperplasia (BPH) is the most common cause of lower urinary tract symptoms in men. When drug treatment is ineffective or conventional surgery is not suitable, novel minimally invasive therapies can be considered. These include prostatic urethral lift, prostatic artery embolisation, water vapor thermal therapy, Aquablation-image guided robotic waterjet ablation, temporary implantable nitinol device and prostatic stents. These novel therapies can be performed in outpatient setting under local anesthesia, with shorter operative and recovery times, and better protection of ejaculatory function and erectile function. General conditions of the patient and advantages and disadvantages of the each of these therapies should be fully considered to make individualized plans.</description><subject>Embolization, Therapeutic - adverse effects</subject><subject>Humans</subject><subject>Lower Urinary Tract Symptoms - etiology</subject><subject>Lower Urinary Tract Symptoms - surgery</subject><subject>Male</subject><subject>Minimally Invasive Surgical Procedures</subject><subject>Prostatic Hyperplasia - complications</subject><subject>Prostatic Hyperplasia - surgery</subject><subject>Stents - adverse effects</subject><subject>Treatment Outcome</subject><issn>1008-9292</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kDtPAzEQhF2ASBTyA2iQS5oDP8--EkWQIEWiAGrLvqyJ0b04X6Icvx5HCTS7WmlmNPshdEPJPVdMPPxsDm48uIwRxjIiC36BppQQnRWsYBM0j_GLEMIkUZrRKzRJJs2TYIqWb-GAm3YPFa5DE2pbVSMOzd7GsAc8bKG3XYCIfdtjB034bHDXt3GwQyjxduyg76qktdfo0tsqwvy8Z-jj-el9scrWr8uXxeM6K6mgPPO518IJL7zj1irCi1yC9QVxoMqSSdC5ll6B44oyBZwWHkQ601BES-AzdHfKTS2-dxAHU4dYQlXZBtpdNEwzLgrJeJ6k9CQtU-HYgzddnx7sR0OJOWIzZ2zmiM0csSXP7Tl-52rY_Dv-gPFfAFxtSA</recordid><startdate>20230425</startdate><enddate>20230425</enddate><creator>Niu, Xinyang</creator><creator>Liu, Ben</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20230425</creationdate><title>Six novel minimally invasive therapies for benign prostatic hyperplasia</title><author>Niu, Xinyang ; Liu, Ben</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1413-f6f84b4f4fb3aa703965eaf90be7cc25e8685f7eb37127e319fe47ebe477085e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Embolization, Therapeutic - adverse effects</topic><topic>Humans</topic><topic>Lower Urinary Tract Symptoms - etiology</topic><topic>Lower Urinary Tract Symptoms - surgery</topic><topic>Male</topic><topic>Minimally Invasive Surgical Procedures</topic><topic>Prostatic Hyperplasia - complications</topic><topic>Prostatic Hyperplasia - surgery</topic><topic>Stents - adverse effects</topic><topic>Treatment Outcome</topic><toplevel>online_resources</toplevel><creatorcontrib>Niu, Xinyang</creatorcontrib><creatorcontrib>Liu, Ben</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Zhejiang da xue xue bao. Journal of Zhejiang University. Medical sciences. Yi xue ban</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Niu, Xinyang</au><au>Liu, Ben</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Six novel minimally invasive therapies for benign prostatic hyperplasia</atitle><jtitle>Zhejiang da xue xue bao. Journal of Zhejiang University. Medical sciences. Yi xue ban</jtitle><addtitle>Zhejiang Da Xue Xue Bao Yi Xue Ban</addtitle><date>2023-04-25</date><risdate>2023</risdate><volume>52</volume><issue>2</issue><spage>162</spage><epage>168</epage><pages>162-168</pages><issn>1008-9292</issn><abstract>Benign prostatic hyperplasia (BPH) is the most common cause of lower urinary tract symptoms in men. When drug treatment is ineffective or conventional surgery is not suitable, novel minimally invasive therapies can be considered. These include prostatic urethral lift, prostatic artery embolisation, water vapor thermal therapy, Aquablation-image guided robotic waterjet ablation, temporary implantable nitinol device and prostatic stents. These novel therapies can be performed in outpatient setting under local anesthesia, with shorter operative and recovery times, and better protection of ejaculatory function and erectile function. General conditions of the patient and advantages and disadvantages of the each of these therapies should be fully considered to make individualized plans.</abstract><cop>China</cop><pmid>37283100</pmid><doi>10.3724/zdxbyxb-2022-0593</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1008-9292 |
| ispartof | Zhejiang da xue xue bao. Journal of Zhejiang University. Medical sciences. Yi xue ban, 2023-04, Vol.52 (2), p.162-168 |
| issn | 1008-9292 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2823495236 |
| source | PubMed (Medline); MEDLINE |
| subjects | Embolization, Therapeutic - adverse effects Humans Lower Urinary Tract Symptoms - etiology Lower Urinary Tract Symptoms - surgery Male Minimally Invasive Surgical Procedures Prostatic Hyperplasia - complications Prostatic Hyperplasia - surgery Stents - adverse effects Treatment Outcome |
| title | Six novel minimally invasive therapies for benign prostatic hyperplasia |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T17%3A21%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Six%20novel%20minimally%20invasive%20therapies%20for%20benign%20prostatic%20hyperplasia&rft.jtitle=Zhejiang%20da%20xue%20xue%20bao.%20Journal%20of%20Zhejiang%20University.%20Medical%20sciences.%20Yi%20xue%20ban&rft.au=Niu,%20Xinyang&rft.date=2023-04-25&rft.volume=52&rft.issue=2&rft.spage=162&rft.epage=168&rft.pages=162-168&rft.issn=1008-9292&rft_id=info:doi/10.3724/zdxbyxb-2022-0593&rft_dat=%3Cproquest_cross%3E2823495236%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2823495236&rft_id=info:pmid/37283100&rfr_iscdi=true |